Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Fusion Pharmaceuticals Inc.
The treatment regimen will consist of 4 doses of FPI-2265, administered at 8 ± 1 week intervals, with an initial activity of 100 kilobecquerel (kBq)/kg (±10%). Additional doses will be administered at 100 kBq/kg (±10%) with the following exceptions: * Participants who experience dose-modifying events. * Participants with a confirmed decline in PSA\>=50%.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted